TY - JOUR AU - Aguilar, M. I. AU - Hart, R. PY - 2005 DA - 2005// TI - Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks JO - Cochrane Database Syst Rev. VL - 3 ID - Aguilar2005 ER - TY - JOUR AU - Wadelius, M. AU - Pirmohamed, M. PY - 2007 DA - 2007// TI - Pharmacogenetics of warfarin: current status and future challenges JO - Pharmacogenomics J VL - 7 UR - https://doi.org/10.1038/sj.tpj.6500417 DO - 10.1038/sj.tpj.6500417 ID - Wadelius2007 ER - TY - JOUR AU - Connock, M. AU - Stevens, C. AU - Fry-Smith, A. AU - Jowett, S. AU - Fitzmaurice, D. AU - Moore, D. PY - 2007 DA - 2007// TI - Clinical effectiveness and cost-effectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling JO - Health Technol Assess VL - 11 UR - https://doi.org/10.3310/hta11380 DO - 10.3310/hta11380 ID - Connock2007 ER - TY - JOUR AU - Poller, L. AU - Shiach, C. R. AU - MacCallum, P. K. AU - Johansen, A. M. AU - Munster, A. M. AU - Magalhaes, A. PY - 1998 DA - 1998// TI - Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation JO - Lancet. VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)04147-6 DO - 10.1016/S0140-6736(98)04147-6 ID - Poller1998 ER - TY - JOUR AU - Crowther, M. A. PY - 2003 DA - 2003// TI - Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms JO - Semin Vasc Med VL - 3 UR - https://doi.org/10.1055/s-2003-44461 DO - 10.1055/s-2003-44461 ID - Crowther2003 ER - TY - JOUR AU - Holbrook, A. AU - Schulman, S. AU - Witt, D. M. AU - Vandvik, P. O. AU - Fish, J. AU - Kovacs, M. J. PY - 2012 DA - 2012// TI - Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 ID - Holbrook2012 ER - TY - JOUR AU - Pirmohamed, M. AU - James, S. AU - Meakin, S. AU - Green, C. AU - Scott, A. K. AU - Walley, T. J. PY - 2004 DA - 2004// TI - Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients JO - BMJ VL - 329 UR - https://doi.org/10.1136/bmj.329.7456.15 DO - 10.1136/bmj.329.7456.15 ID - Pirmohamed2004 ER - TY - JOUR AU - Jorgensen, A. L. AU - FitzGerald, R. J. AU - Oyee, J. AU - Pirmohamed, M. AU - Williamson, P. R. PY - 2012 DA - 2012// TI - Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0044064 DO - 10.1371/journal.pone.0044064 ID - Jorgensen2012 ER - TY - JOUR AU - Lee, M. T. AU - Klein, T. E. PY - 2013 DA - 2013// TI - Pharmacogenetics of warfarin: challenges and opportunities JO - J Hum Genet VL - 58 UR - https://doi.org/10.1038/jhg.2013.40 DO - 10.1038/jhg.2013.40 ID - Lee2013 ER - TY - JOUR AU - Finkelman, B. S. AU - Gage, B. F. AU - Johnson, J. A. AU - Brensinger, C. M. AU - Kimmel, S. E. PY - 2011 DA - 2011// TI - Genetic warfarin dosing: tables versus algorithms JO - J Am Coll Cardiol VL - 57 UR - https://doi.org/10.1016/j.jacc.2010.08.643 DO - 10.1016/j.jacc.2010.08.643 ID - Finkelman2011 ER - TY - JOUR AU - Pirmohamed, M. AU - Burnside, G. AU - Eriksson, N. AU - Jorgensen, A. L. AU - Toh, C. H. AU - Nicholson, T. PY - 2013 DA - 2013// TI - A randomized trial of genotype-guided dosing of warfarin JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1311386 DO - 10.1056/NEJMoa1311386 ID - Pirmohamed2013 ER - TY - JOUR AU - Kimmel, S. E. AU - French, B. AU - Kasner, S. E. AU - Johnson, J. A. AU - Anderson, J. L. AU - Gage, B. F. PY - 2013 DA - 2013// TI - A pharmacogenetic versus a clinical algorithm for warfarin dosing JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1310669 DO - 10.1056/NEJMoa1310669 ID - Kimmel2013 ER - TY - JOUR AU - Maitland-van der Zee, A. H. AU - Daly, A. K. AU - Kamali, F. AU - Manolopoulous, V. G. AU - Verhoef, T. I. AU - Wadelius, M. PY - 2014 DA - 2014// TI - Patients benefit from genetics-guided coumarin anticoagulant therapy JO - Clin Pharmacol Ther VL - 96 UR - https://doi.org/10.1038/clpt.2014.44 DO - 10.1038/clpt.2014.44 ID - Maitland-van der Zee2014 ER - TY - JOUR AU - Jorgensen, A. L. AU - Al-Zubiedi, S. AU - Zhang, J. E. AU - Keniry, A. AU - Hanson, A. AU - Hughes, D. A. PY - 2009 DA - 2009// TI - Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study JO - Pharmacogenet Genomics VL - 19 UR - https://doi.org/10.1097/FPC.0b013e3283317ab5 DO - 10.1097/FPC.0b013e3283317ab5 ID - Jorgensen2009 ER - TY - JOUR AU - Saunders, J. B. AU - Aasland, O. G. AU - Babor, T. F. AU - Fuente, J. R. AU - Grant, M. PY - 1993 DA - 1993// TI - Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II JO - Addiction VL - 88 UR - https://doi.org/10.1111/j.1360-0443.1993.tb02093.x DO - 10.1111/j.1360-0443.1993.tb02093.x ID - Saunders1993 ER - TY - JOUR AU - Teo, Y. Y. AU - Inouye, M. AU - Small, K. S. AU - Gwilliam, R. AU - Deloukas, P. AU - Kwiatkowski, D. P. PY - 2007 DA - 2007// TI - A genotype calling algorithm for the Illumina BeadArray platform JO - Bioinformatics VL - 23 UR - https://doi.org/10.1093/bioinformatics/btm443 DO - 10.1093/bioinformatics/btm443 ID - Teo2007 ER - TY - JOUR AU - Purcell, S. AU - Neale, B. AU - Todd-Brown, K. AU - Thomas, L. AU - Ferreira, M. A. AU - Bender, D. PY - 2007 DA - 2007// TI - PLINK: a tool set for whole-genome association and population-based linkage analyses JO - Am J Hum Genet VL - 81 UR - https://doi.org/10.1086/519795 DO - 10.1086/519795 ID - Purcell2007 ER - TY - JOUR AU - Howie, B. N. AU - Donnelly, P. AU - Marchini, J. PY - 2009 DA - 2009// TI - A flexible and accurate genotype imputation method for the next generation of genome-wide association studies JO - PLoS Genet VL - 5 UR - https://doi.org/10.1371/journal.pgen.1000529 DO - 10.1371/journal.pgen.1000529 ID - Howie2009 ER - TY - JOUR AU - Marchini, J. AU - Howie, B. PY - 2010 DA - 2010// TI - Genotype imputation for genome-wide association studies JO - Nat Rev Genet VL - 11 UR - https://doi.org/10.1038/nrg2796 DO - 10.1038/nrg2796 ID - Marchini2010 ER - TY - JOUR AU - Barnes, C. AU - Plagnol, V. AU - Fitzgerald, T. AU - Redon, R. AU - Marchini, J. AU - Clayton, D. PY - 2008 DA - 2008// TI - A robust statistical method for case–control association testing with copy number variation JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.206 DO - 10.1038/ng.206 ID - Barnes2008 ER - TY - JOUR AU - Wadelius, M. AU - Chen, L. Y. AU - Eriksson, N. AU - Bumpstead, S. AU - Ghori, J. AU - Wadelius, C. PY - 2007 DA - 2007// TI - Association of warfarin dose with genes involved in its action and metabolism JO - Hum Genet VL - 121 UR - https://doi.org/10.1007/s00439-006-0260-8 DO - 10.1007/s00439-006-0260-8 ID - Wadelius2007 ER - TY - JOUR AU - Caldwell, M. D. AU - Awad, T. AU - Johnson, J. A. AU - Gage, B. F. AU - Falkowski, M. AU - Gardina, P. PY - 2008 DA - 2008// TI - CYP4F2 genetic variant alters required warfarin dose JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-11-122010 DO - 10.1182/blood-2007-11-122010 ID - Caldwell2008 ER - TY - JOUR AU - Takeuchi, F. AU - McGinnis, R. AU - Bourgeois, S. AU - Barnes, C. AU - Eriksson, N. AU - Soranzo, N. PY - 2009 DA - 2009// TI - A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose JO - PLoS Genet VL - 5 UR - https://doi.org/10.1371/journal.pgen.1000433 DO - 10.1371/journal.pgen.1000433 ID - Takeuchi2009 ER - TY - JOUR AU - Nostrand, W. E. AU - Wagner, S. L. AU - Farrow, J. S. AU - Cunningham, D. D. PY - 1990 DA - 1990// TI - Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor JO - J Biol Chem VL - 265 ID - Nostrand1990 ER - TY - JOUR AU - Xu, F. AU - Previti, M. L. AU - Nieman, M. T. AU - Davis, J. AU - Schmaier, A. H. AU - Nostrand, W. E. PY - 2009 DA - 2009// TI - AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis JO - J Neurosci VL - 29 UR - https://doi.org/10.1523/JNEUROSCI.0095-09.2009 DO - 10.1523/JNEUROSCI.0095-09.2009 ID - Xu2009 ER - TY - JOUR AU - Ganesh, S. K. AU - Zakai, N. A. AU - Rooij, F. J. AU - Soranzo, N. AU - Smith, A. V. AU - Nalls, M. A. PY - 2009 DA - 2009// TI - Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium JO - Nat Genet VL - 41 UR - https://doi.org/10.1038/ng.466 DO - 10.1038/ng.466 ID - Ganesh2009 ER - TY - JOUR AU - Loebstein, R. AU - Yonath, H. AU - Peleg, D. AU - Almog, S. AU - Rotenberg, M. AU - Lubetsky, A. PY - 2001 DA - 2001// TI - Interindividual variability in sensitivity to warfarin--Nature or nurture? JO - Clin Pharmacol Ther VL - 70 UR - https://doi.org/10.1067/mcp.2001.117444 DO - 10.1067/mcp.2001.117444 ID - Loebstein2001 ER - TY - JOUR AU - Rettie, A. E. AU - Wienkers, L. C. AU - Gonzalez, F. J. AU - Trager, W. F. AU - Korzekwa, K. R. PY - 1994 DA - 1994// TI - Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9 JO - Pharmacogenetics VL - 4 UR - https://doi.org/10.1097/00008571-199402000-00005 DO - 10.1097/00008571-199402000-00005 ID - Rettie1994 ER - TY - JOUR AU - Rieder, M. J. AU - Reiner, A. P. AU - Gage, B. F. AU - Nickerson, D. A. AU - Eby, C. S. AU - McLeod, H. L. PY - 2005 DA - 2005// TI - Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa044503 DO - 10.1056/NEJMoa044503 ID - Rieder2005 ER - TY - JOUR AU - Yuan, H. Y. AU - Chen, J. J. AU - Lee, M. T. AU - Wung, J. C. AU - Chen, Y. F. AU - Charng, M. J. PY - 2005 DA - 2005// TI - A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity JO - Hum Mol Genet VL - 14 UR - https://doi.org/10.1093/hmg/ddi180 DO - 10.1093/hmg/ddi180 ID - Yuan2005 ER - TY - JOUR AU - Limdi, N. A. AU - Wadelius, M. AU - Cavallari, L. AU - Eriksson, N. AU - Crawford, D. C. AU - Lee, M. T. PY - 2010 DA - 2010// TI - Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-12-255992 DO - 10.1182/blood-2009-12-255992 ID - Limdi2010 ER - TY - JOUR AU - Wadelius, M. AU - Chen, L. Y. AU - Downes, K. AU - Ghori, J. AU - Hunt, S. AU - Eriksson, N. PY - 2005 DA - 2005// TI - Common VKORC1 and GGCX polymorphisms associated with warfarin dose JO - Pharmacogenomics J VL - 5 UR - https://doi.org/10.1038/sj.tpj.6500313 DO - 10.1038/sj.tpj.6500313 ID - Wadelius2005 ER - TY - JOUR AU - D’Andrea, G. AU - D'Ambrosio, R. L. AU - Perna, P. AU - Chetta, M. AU - Santacroce, R. AU - Brancaccio, V. PY - 2005 DA - 2005// TI - A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin JO - Blood VL - 105 UR - https://doi.org/10.1182/blood-2004-06-2111 DO - 10.1182/blood-2004-06-2111 ID - D’Andrea2005 ER - TY - JOUR AU - Wadelius, M. AU - Chen, L. Y. AU - Lindh, J. D. AU - Eriksson, N. AU - Ghori, M. J. AU - Bumpstead, S. PY - 2009 DA - 2009// TI - The largest prospective warfarin-treated cohort supports genetic forecasting JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-04-149070 DO - 10.1182/blood-2008-04-149070 ID - Wadelius2009 ER - TY - JOUR AU - Furuya, H. AU - Fernandez-Salguero, P. AU - Gregory, W. AU - Taber, H. AU - Steward, A. AU - Gonzalez, F. J. PY - 1995 DA - 1995// TI - Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy JO - Pharmacogenetics VL - 5 UR - https://doi.org/10.1097/00008571-199512000-00008 DO - 10.1097/00008571-199512000-00008 ID - Furuya1995 ER - TY - JOUR AU - Aithal, G. P. AU - Day, C. P. AU - Kesteven, P. J. AU - Daly, A. K. PY - 1999 DA - 1999// TI - Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)04474-2 DO - 10.1016/S0140-6736(98)04474-2 ID - Aithal1999 ER - TY - JOUR AU - Tabrizi, A. R. AU - Zehnbauer, B. A. AU - Borecki, I. B. AU - McGrath, S. D. AU - Buchman, T. G. AU - Freeman, B. D. PY - 2002 DA - 2002// TI - The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin JO - J Am Coll Surg VL - 194 UR - https://doi.org/10.1016/S1072-7515(01)01163-2 DO - 10.1016/S1072-7515(01)01163-2 ID - Tabrizi2002 ER - TY - JOUR AU - Hamberg, A. K. AU - Wadelius, M. AU - Lindh, J. D. AU - Dahl, M. L. AU - Padrini, R. AU - Deloukas, P. PY - 2010 DA - 2010// TI - A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2010.37 DO - 10.1038/clpt.2010.37 ID - Hamberg2010 ER - TY - JOUR AU - Lenzini, P. AU - Wadelius, M. AU - Kimmel, S. AU - Anderson, J. L. AU - Jorgensen, A. L. AU - Pirmohamed, M. PY - 2010 DA - 2010// TI - Integration of genetic, clinical, and INR data to refine warfarin dosing JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2010.13 DO - 10.1038/clpt.2010.13 ID - Lenzini2010 ER - TY - JOUR AU - Plowchalk, D. R. AU - Rowland, Y. K. PY - 2012 DA - 2012// TI - Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2 JO - Eur J Clin Pharmacol VL - 68 UR - https://doi.org/10.1007/s00228-011-1189-y DO - 10.1007/s00228-011-1189-y ID - Plowchalk2012 ER - TY - JOUR AU - Avery, P. J. AU - Jorgensen, A. AU - Hamberg, A. K. AU - Wadelius, M. AU - Pirmohamed, M. AU - Kamali, F. PY - 2011 DA - 2011// TI - A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy JO - Clin Pharmacol Ther VL - 90 UR - https://doi.org/10.1038/clpt.2011.186 DO - 10.1038/clpt.2011.186 ID - Avery2011 ER - TY - JOUR AU - Rouaud, A. AU - Hanon, O. AU - Boureau, A. S. AU - Chapelet, G. AU - Decker, L. PY - 2015 DA - 2015// TI - Comorbidities against quality control of VKA therapy in non-valvular atrial fibrillation: a French national cross-sectional study JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119043 DO - 10.1371/journal.pone.0119043 ID - Rouaud2015 ER - TY - JOUR AU - Ohara, M. AU - Takahashi, H. AU - Lee, M. T. AU - Wen, M. S. AU - Lee, T. H. AU - Chuang, H. P. PY - 2014 DA - 2014// TI - Determinants of the over-anticoagulation response during warfarin initiation therapy in Asian patients based on population pharmacokinetic-pharmacodynamic analyses JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0105891 DO - 10.1371/journal.pone.0105891 ID - Ohara2014 ER - TY - JOUR AU - Oliveira Almeida, V. C. AU - Ribeiro, D. D. AU - Gomes, K. B. AU - Godard, A. L. PY - 2014 DA - 2014// TI - Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study JO - Mol Diagn Ther VL - 18 UR - https://doi.org/10.1007/s40291-014-0121-4 DO - 10.1007/s40291-014-0121-4 ID - Oliveira Almeida2014 ER -